British American Tobacco (BAT), the maker of Dunhill cigarettes, announced on Monday it would cut approximately 5,500 jobs globally and transition a further 3,500 roles to third-party outsourcing firms, including Accenture, bringing the total number of affected employees to roughly 9,000. The restructuring, which excludes the United States, the company's largest market, is part of BAT’s internally branded ‘Fit2Win’ productivity transformation.
The programme is projected to deliver £600 million (approximately $793 million) in additional annualised cost savings by 2028, with £500 million targeted as early as 2027. Despite the announcement, BAT's shares fell 1.6% to £46.73 on Monday, underperforming the broader FTSE 100 index, which declined 0.3%.
Chief Executive Tadeu Marroco described the overhaul as necessary to make the organisation "more agile, cost-disciplined and technology-enabled," while pledging care for displaced staff. Barclays analyst Pallav Mittal noted, however, that while the company had flagged restructuring in February, the scale of the cuts "may surprise investors."
The Root Cause: Terminal Decline of Traditional Cigarettes
The job cuts are not merely a cost-cutting exercise; they reflect a structural crisis at the core of BAT's primary business. Traditional cigarette volumes are in what analysts describe as terminal decline. BAT itself forecasts a 2.5% drop in industry-wide cigarette sales volumes this year alone , a trend driven by tightening regulations, illicit trade, rising duties, and consumers trading down to cheaper brands under cost-of-living pressures.
Markets including Australia and Bangladesh are cited among the most challenging, affected by rising duties, stricter regulations, and growing illicit trade. In the United States, smokers have increasingly migrated to budget alternatives, eroding BAT's premium market share. The company's revenue and profit growth have been described as "sluggish," frequently falling short of or barely meeting internal targets , a pattern that has disappointed investors.
AI and automation, therefore, serve a dual financial purpose: immediately slashing operational costs in the declining cigarette business, while simultaneously freeing capital to fund a pivot towards what BAT terms 'New Category' products.
The Pivot: Vapes, Nicotine Pouches and 'New Category' ProductsThe revenue secured through AI-driven corporate downsizing is being funnelled directly into researching, developing, and marketing non-combustible alternatives. BAT's flagship smokeless products, Vuse vapes and Velo nicotine pouches, are currently delivering double-digit revenue growth and represent the company's strategic bet on its post-cigarette future.
AI tools are being deployed across the supply chain of these new products: optimising inventory management, accelerating digital product design cycles, and fast-tracking time-to-market to better compete with rivals. BAT's key competitor, Philip Morris International, is widely considered to have a head-start in this transition, adding competitive urgency to BAT's overhaul.
However, the pivot has not been without setbacks. United States regulators have adopted a stringent posture on licensing new vaping products, causing significant delays to market entry. BAT has argued that these regulatory bottlenecks have inadvertently fuelled an influx of illegal Chinese vaping products, compounding its sales and market share challenges in its most important market.
The Other Side: AI Fighting Tobacco AddictionWhile tobacco corporations harness AI to extend their commercial viability, public health authorities and medical researchers are deploying the same technology to counter the industry's influence and support smokers seeking to quit.
Infoveillance: Generative AI and computer vision models are being trained to scan social media platforms in real time, automatically identifying unauthorised tobacco-promoting content and influencer-driven e-cigarette marketing aimed at minors.
Predictive Cessation Support: Machine learning algorithms analyse individual user behavioural data to calculate tobacco initiation risks, model relapse probability, and personalise quitting interventions at scale.
AI Chatbots for Craving Management: Conversational AI applications deliver personalised, real-time motivational support to smokers experiencing acute cravings, extending the reach of cessation programmes beyond the capacity of human counsellors.
Factory Quality Control: On the manufacturing floor, AI-driven convolutional neural networks and advanced computer vision systems have largely replaced manual defect inspection in cigarette production lines, reducing human error and increasing throughput.
A Technology with Two FacesThe convergence of artificial intelligence with the tobacco industry encapsulates a broader tension inherent to powerful technology: the same tools being used to sustain a business model built around an addictive and lethal product are simultaneously being deployed to detect its illegal promotion and help its victims quit. BAT's restructuring announcement marks a turning point , not just for a single company, but for how a legacy industry attempts to adapt to changing consumer behaviour, regulatory pressure, and the disruptive logic of automation.
Whether the pivot to vapes and nicotine pouches constitutes a genuine harm-reduction transition or simply a rebranding of addiction remains a question that regulators, health authorities, and policymakers, armed increasingly with their own AI tools, are actively contesting.
IF
